Placeholder Image

Subtitles section Play video

  • The following content is provided under a Creative

  • Commons license.

  • Your support will help MIT OpenCourseWare

  • continue to offer high-quality educational resources for free.

  • To make a donation or view additional materials

  • from hundreds of MIT courses, visit MIT OpenCourseWare

  • at ocw.mit.edu.

  • JOANNE STUBBE: The last time, we were finishing the first part

  • of the reactive oxygen species module, focused

  • on how we as humans fight bacterial or viral infections

  • using neutrophils, the white blood cells.

  • And I introduced you to this cartoon.

  • So here's our neutrophil, all of this blue stuff.

  • It has an unusual-looking nucleus.

  • Neutrophils have weird nuclei.

  • They somehow sense the bacteria you saw, the bacteria getting

  • chased by the neutrophil.

  • And then somebody asked me this question.

  • Somebody asked me this question last time

  • about where the NOX2 proteins end up.

  • And let me reiterate again that they can

  • be found in multiple membranes.

  • The predominant membrane in neutrophils

  • is in these little vesicles within the cell,

  • OK, but the bacteria out here, so they need

  • to somehow engulf the bacteria.

  • So they can also be found in the plasma membrane.

  • And they need to engulf the bacteria to form phagosomes.

  • And so here you see them again.

  • So this is the phagosome with the NOX2 protein,

  • with this predisposition where the NADPH is in the cytosol.

  • OK?

  • So you see that the location here, the NADPH

  • is also in the cytosol.

  • And so you need to think about where you're located.

  • And we'll see in a few minutes that there

  • are lots of different kinds of NOX proteins,

  • and they all have different locations

  • and all have different factors that

  • control the regulation of all of these things.

  • OK, so what I want to do today is start out by looking,

  • talking about the NOX complex, what the chemistry is,

  • because it's not only involved in killing bacteria,

  • but we'll see-- and you've already seen in last

  • week's recitation--

  • in the signaling process.

  • It's the same protein.

  • And so once the bacteria are engulfed,

  • you now have a phagosome within the neutrophil.

  • And here's the NOX complex.

  • Remember, it's composed of two proteins,

  • the 91-kilodalton glycoprotein and a 22-kilodalton protein,

  • both membrane-bound.

  • I drew those on the board last time.

  • And the NADPH/NADP is in the cytosol.

  • But all the chemistry is going to happen

  • in the lumen of the phagosome.

  • OK, so somehow the reducing equivalents from the NADPH

  • need to be transferred into the lumen, where oxygen is going

  • to be reduced to superoxide.

  • So I want to talk a little bit about how that happens first,

  • given what we know about the cofactors in NOX2 that

  • are essential for this process.

  • And then what we'll do is look a little bit at how

  • the superoxide that's generated in the phagosome

  • gets converted to hydrogen peroxide,

  • and ultimately with another protein

  • we're briefly going to discuss, a heme-dependent protein,

  • myeloperoxidase, which uses chloride,

  • can form hypochlorous acid.

  • OK?

  • So that's where we're going.

  • This is a cartoon I drew on the board

  • the last time, where you can see that we

  • have a flavin domain, a flavin domain that's

  • located in the cytosol.

  • And then you have two hemes.

  • And the unusual part about this system is that these hemes--

  • we've seen heme before with reversible binding of oxygen

  • in hemoglobin-- they're both hexacoordinate.

  • So there's no binding site for oxygen.

  • So the chemistry is not happening by reversible binding

  • of oxygen to the heme.

  • In fact, you know, how close this is located to the surface,

  • we don't have any structure of this,

  • but somehow this reduction has to occur

  • by an electron transfer process that

  • probably occurs through the edge of the perforin system.

  • So what you have here-- and I think

  • this is an important teaching point,

  • because I think there are only two ways inside the cell

  • that you control all the redox balance.

  • The redox balance within NADPH and flavins

  • really play a central role in everything,

  • so you really need to understand how these cofactors work,

  • and how they're controlled.

  • And so if you have a flavin--

  • and this is also written-- you don't have to write this down.

  • This is written on the next handout,

  • so you don't have to draw all this stuff out.

  • OK, so I'm going to draw the business end of the flavin.

  • OK, so this can be flavin adenine dinucleotide.

  • So this is the oxidized state.

  • And the two important places where redox chem--

  • redox chemistry, but look at flavin.

  • If you don't know anything about heterocyclic chemistry,

  • it's confusing.

  • But in fact, we know a huge amount about flavin chemistry

  • from studying model reactions in organic chemistry.

  • Decades ago, Tom Bruce did that.

  • And so the two places where the chemistry in general happen

  • are either the inside--

  • so this is 1, 2, 3, 4.

  • This is the N5--

  • or the C4A position, and this is the C4A position here.

  • And I'm not going to go through this in detail

  • but this is the oxidized form, and what

  • we have is the reaction of this oxidized form with the reduced

  • form of NADPH.

  • And I'm not going to draw out the whole structure here

  • either.

  • But hopefully you all know now that NADPH and general

  • works by hydride transfer, so it's almost always a two

  • electron transfer.

  • The one electron chemistry is really

  • outside the realm where it would normally

  • happen inside the cell.

  • So basically the chemistry involves

  • transfer of a hydride, a hydrogen

  • with a pair of electrons to the N5 position.

  • And so you go from the oxidized state to the reduced state.

  • And so again I'm not going to draw out the whole flavin.

  • The rest of the--

  • I guess I don't have a picture there but--

  • well, let me just show you where we're going.

  • So the key is, which is interesting about this,

  • we need to get across a membrane.

  • So how do you get across a membrane?

  • So the flavin domain is way over here,

  • and we need to have two hemes.

  • Remember you can do electron transfer over 10 to 15 axioms

  • with very fast rate constants.

  • Somehow these reducing equivalents from NADPH

  • need to be transferred to the flavin.

  • And the major function of the flavin inside the cell

  • is to mediate two electron one electron chemistry.

  • And here's an example that.

  • The two-electron chemistry is being provided

  • by the NADPH ass a hydride.

  • But what we have to do is the hemes in this system are

  • in the plus 3 oxidation state, so what

  • we need to do is be able to convert-- ultimately

  • we want to reduce oxygen to super oxides,

  • so we need an electron.

  • So that electron is coming from NADPH.

  • So we need to have an electron transfer--

  • a single electron transfer to the heme because it only can--

  • iron can only be reduced by one electron.

  • So we end up then with this system.

  • So this is the reduced state of the flavin.

  • And you can draw a resonance structure.

  • This is deep-- you can draw all kinds of resonance structures

  • with flavins.

  • That's why I can they can do one-electron chemistry.

  • So one-electron chemistry, you can make the one electron

  • oxidized a reduced state depending

  • on which state you're starting in

  • and the electrons are delocalized.

  • They turn out to be blue, or they turn out

  • to be red depending on the prognation states.

  • So what you can then do is--

  • let me just write that over here.

  • So I'm just drawing a resonance structure of that

  • so you can see--

  • let me not.

  • And again let me just show you that that's there so you

  • don't need to write that down.

  • You don't need to write this down.

  • It's all there.

  • So just pay attention to me.

  • So you're going to do an electron transfer to reduce

  • an iron 3 to an iron 2.

  • Then you've got another iron 3 because we got

  • to get through this membrane.

  • So that heme-- and again, this is where the redox potentials

  • become critical--

  • can transfer an electron because now in the reduced state

  • to the other heme so that becomes in the iron 2 state.

  • So the one out here is in the iron 2 the state.

  • Now it can transfer electron from oxygen

  • to form super oxide.

  • But at the same time during this process,

  • we're transferring the two electrons

  • that the Flavin received from the NADPH one at a time,

  • so then we can repeat that process.

  • And that's why you get the stochiometry

  • of the overall reaction.

  • You get two super oxides produced.

  • So you have a resonance form of this.

  • Let me see.

  • I think I need to write over here.

  • So anyhow you have a resonance form of this where you--

  • And now we're ready to do-- so this is the same as--

  • so this is a resonance form.

  • These are the same structures.

  • In the flavin, this is attached either to adenine

  • or to a ribose biphosphate FMN versus FAD.

  • And now what you're ready to do is you have the heme.

  • And so the heme again is embedded in the membrane.

  • And so now what you're doing is electron transfer.

  • So you do an electron transfer reaction

  • and you get this structure.

  • So make a big dot for the radical.

  • And now we've reduced one of the hemes to iron 2.

  • And if you look at the redoxx potentials--

  • I haven't ever read these original papers--

  • but they're close to being matched

  • in terms of redox potentials.

  • I haven't read how they measured these kinds of things,

  • but the system needs to be set up so that you

  • can do transfer the electrons across the membrane

  • and ultimately reduce the super oxide over here.

  • And so now what happens so you've gotten to this stage.

  • So now you have a semi quinone form of the flavin.

  • this guy can then be re-oxidized by the next heme,

  • generating the iron 2 form and regenerating the iron 3 form.

  • So this guy then--

  • so let's-- to distinguish between them--

  • again I don't think this-- hopefully most of you were

  • seeing this, but you have another one,

  • so it donates an electron to covert the iron 3 form so we

  • have an iron 3 form to the iron to form.

  • And it itself becomes re-oxidized.

  • And so now what's happening is you're

  • set up to do another electron transfer where this is going

  • to go to the iron 3, transfer it again, and in the end

  • this guy is now in the lumen--

  • adjacent to the lumen.

  • I don't know where it's located.

  • We don't have a structure but this guy

  • is probably through the hemage going to convert oxygen

  • into super oxide.

  • So is everybody following that?

  • The main point here is you all hear about the flavin

  • being the major mediator between one-electron chemistry

  • and two-electron chemistry.

  • Most of the time people don't draw out the details of this,

  • but these things can all be observed spectroscopically

  • because they're colored.

  • Yeah.

  • The second iron reduction happens

  • from the semi [INAUDIBLE]?

  • JOANNE STUBBE: The second iron-- yeah.

  • Happens from the semi--

  • AUDIENCE: So you generate your process.

  • JOANNE STUBBE: Right.

  • Right.

  • So you regenerate the oxidized form, so in the end over here,

  • you go all the way through this.

  • And again I haven't looked at the kinetics in the paper

  • very carefully, but it very efficiently

  • does this and shuttles the electron across.

  • So you're doing the same thing.

  • You're reorganizing the reduced form of the flavin,

  • but you're doing it one electron at a time.

  • So here's the key take home message.

  • So all of this then happens in the phagosome.

  • And so what you're generating then is superoxide, OK?

  • Now what happens to superoxide?

  • So superoxide could potentially do chemistry,

  • but we talked about, last time, what are

  • the properties of superoxide?

  • It's not all that reactive, and frankly having

  • read a lot of papers, I think we don't really

  • understand all the details of how the bacteria die when

  • they're engulfed by the phagosome--

  • but a key player in all in this overall process.

  • And it's certainly not the only player,

  • because you can actually wipe out my myloperoxidase,

  • and you can still kill bacteria.

  • So it's much more complicated than what

  • I'm telling you, but a key player in when

  • most people describe this is myloperoxidase,

  • which is a heme protein.

  • I'll show you that in a minute.

  • But it turns out that these myloperoxidases

  • exist in little granules.

  • Just like you saw the little vesicle with the NOX2

  • it, that was predominantly sitting inside the neutrophil,

  • you also have little vesicles.

  • And the vesicles are stuffed with myloperoxidase.

  • And somehow there's a signal, and the myloperoxidase then

  • fuses with the phagosome.

  • So this is a phagosome, and you have a huge amount of protein

  • in there.

  • It gets dumped into the phagosome,

  • so you have a heme protein.

  • And that one's dumped in here.

  • Inside the cell, you generated a gradient,

  • so there's some complicated independent reactions.

  • You need to sort of neutralize the pH, which happens.

  • But once you get inside the cell of the myloperoxidase,

  • the protonation state is such that you can rapidly

  • protinate superoxide to hydrogen peroxide,

  • and we'll see that hydrogen peroxide reacts

  • with myloperoxidase, which then reacts with chloride

  • which is also present.

  • In the hypochlorus acid, we'll see is a key player,

  • and how can you tell that?

  • Because if you isolate the proteins

  • that come out of the phagosome, they're all chlorinated.

  • So you generate-- if you go back,

  • and you look at the little sheet I showed you about reactivity--

  • hypochlorus acid is really reactive.

  • It's reactive, very reactive kinetically

  • and also thermodynamically.

  • OK, so the myloperoxidase-- so once we

  • get-- so we've gotten our superoxide,

  • so now we're in the phagosome.

  • And now we want to look at myloperoxidase,

  • and so that catalyzes the reaction of hydrogen peroxide

  • and chloride to form hypochlorus acid.

  • And this is myloperoxidase, and it's a heme dependent protein.

  • And so the question is how does this work?

  • And so what do we know about myloperoxidase?

  • People have been studying this for decades,

  • and you're going to see the chemistry is actually

  • quite complicated.

  • It's very important, so people are always

  • trying to figure out the details of the chemistry.

  • But the devil is in the kinetics in the environment

  • of the phagosome, so it's not so easy to sort all this out.

  • But if you look at the structure, number one,

  • you see this is--

  • this is from an X-ray structure.

  • It's bent, so it has an unusual structure.

  • It has an axial ligand that's a histidine,

  • and there's no second axial ligand.

  • And it's covalently bound in two places.

  • There are parts in the heme that are hanging off

  • the protoporphyrin IX, where it's covalently bound

  • to the protein, and the covalent attachment's

  • distinct from most of the heme.

  • So that's all you need to know, in terms of what we're

  • going to be talking about.

  • So you have a heme protein, and most

  • of the time I don't talk about the heme systems.

  • But I think the heme systems--

  • you guys ought to know something about hemes.

  • We've talked about hemes with reversible oxygen binding.

  • You've seen hemes in cholesterol biosynthesis.

  • In many of the natural products, biosynthetic pathways,

  • you have hemes that do hydroxylation reactions

  • or epoxidation reactions.

  • Hemes play a central role in many reactions inside the cell.

  • And this one, the general reaction, I think

  • is pretty straightforward to understand.

  • So what you have-- and so again this straight line

  • is protoporphyrin IX, so I'll just write protoporphyrin IX.

  • And again, it's ligated to histidine,

  • so this is part of the protein.

  • And there's no second axial ligand.

  • You take the superoxide which rapidly disproportionates,

  • so this can be rapidly disproportionated

  • in the presence of protons to form hydrogen

  • peroxide and oxygen gas.

  • And we've already gone through that reaction.

  • And so now what happens is the peroxide

  • is going to bind to the heme, and so this

  • is the key to the reaction.

  • So you lose a proton, and the oxygen binds to the heme.

  • And you generate that species.

  • Now this species-- and again, this

  • is dependent-- this is where it becomes distinct

  • when trying to think about all the chemistry

  • that hemes can do.

  • You need to look at the two axial ligands,

  • and what the environment is around the ligand.

  • So that's another thing.

  • I've tried to stress how important these ligands are--

  • and the second coordination sphere around the system.

  • So what happens now, in this system,

  • is in some way the enzyme catalyzes heterolytic cleavage

  • of the oxygen oxygen bond, and forms what

  • is formerly an iron IV species.

  • But it's not an iron five species,

  • so we've lost a molecule water.

  • Somehow this leaves as water, so we

  • have some groups in the active site that

  • can facilitate that cleavage.

  • And this is formerly an iron V species,

  • so we're using electrons from the iron porphyrin system

  • to facilitate cleavage of that bond.

  • Now how do we know this?

  • We know this because we know a lot

  • about the spectroscopy of hemes and of the iron in the hemes,

  • and we can actually look at all of these intermediates.

  • And so what does this mean here?

  • What happens is-- remember your porphyrin.

  • Well, you can see the porphyrin, but you have this.

  • You have all these pyrroles.

  • And so iron V is a hot oxygen. Nobody's

  • ever seen the iron V in any of these systems,

  • so what you see--

  • spectroscopically, you see an iron IV and one electron

  • oxidized porphyrin ring.

  • OK, so that's what this is.

  • This is a one electron oxidized porphyrin ring.

  • So now what do you want to do?

  • In the normal reaction, what you want to do--

  • the one that forms hypochlorus acid is a two-electron

  • reaction, and the chloride can come in--

  • and you're going to form hypochlorus acid.

  • So the chloride comes in and attacks,

  • and one of the electrons goes back to the iron.

  • And the other goes back to the porphyrin.

  • So these one-headed arrows means you're

  • doing one-electron transfers, and so what you've generated

  • then is hypochlorus acid.

  • The pKa of this is 7.4.

  • And then you've generated back your iron III porphyrin,

  • so you're ready to start again.

  • So you're doing a two-electron process,

  • and we know that the driving force for this reaction

  • is large.

  • It's 1.16 volts, so this is a very favorable reaction.

  • Now if any of you have thought about heme-dependent systems--

  • before, if you have an iron oxo, this is a hot oxidant.

  • It's dying to be reduced.

  • It can be two-electron reduced, but it can also

  • be one-electron reduced, depending

  • on what small molecules are around here.

  • And myloperoxidase does both kinds of chemistry.

  • The predominant chemistry-- so this

  • is what you need to look at the rate

  • constants for the reaction.

  • The predominant chemistry is thought to be this,

  • but I will show you a slide where

  • we know it can catalyze a lot of other chemistries

  • by one-electron transfers, as well.

  • And what's happening in the phagosome with the cell,

  • if you want to look at that, the [INAUDIBLE] review article

  • I gave you spent a lot of time thinking

  • about these kinds of reactions.

  • And sort of think it's beyond the scope of what

  • we need to talk about.

  • So here what we have happening-- so here now I'm just going to--

  • I'll tell you what R is in a minute,

  • but what we're going to do is have one-electron transfer.

  • And so instead of reducing this two electrons at a time,

  • we're going to do two one-electron transfers, OK?

  • So the system has to be set up.

  • You have to have the right RH.

  • You need to know what the redox potentials of these are--

  • determined by the ligands.

  • All of that stuff, you need to think about.

  • So now we're doing one-electron chemistry,

  • so this is another possibility.

  • And this again depends on how much chloride you have around.

  • It's a potent oxidant, so it can be rapidly reduced,

  • depending on whether you have an RH around that's going

  • to actually do the reduction.

  • And so what you generate then--

  • is you reduce the cation radical, and you form an R dot.

  • And then the next step, which you can do,

  • is a second one-electron reduction,

  • so you're doing two one-electron reductions.

  • And this driving force is not as large--

  • 0.97 volts-- but again it's one-electron.

  • And you're back then to iron III in water.

  • I'm being sloppy about where the protons have come from.

  • And you produced another R dot.

  • So what could these R dots be?

  • One of these R dots is ascorbate, vitamin C. So one

  • of the RH's, which can--

  • the ascorbate can form radicals.

  • I'm not going to go through this in any detail.

  • Another RH could be tyrosines.

  • So this is the amino acid tyrosine,

  • and you form tyrosyl radicals.

  • Has anybody ever seen that before in our department?

  • Anybody seen use of this before?

  • AUDIENCE: Apex?

  • JOANNE STUBBE: Yeah.

  • So, Apex.

  • So this is the technology that is the basis.

  • She doesn't use myloperoxidase, but King's Lab--

  • it uses a ascorbate peroxidase, which

  • catalyzes a similar reaction.

  • So your R dot then becomes a phenoxide radical.

  • And that can then do for the chemistry.

  • Anyhow, so what you're generating,

  • most people believe the key bad player in all of this,

  • but I'm just telling you it's more complicated than that,

  • is the hypochlorus acid, which clearly gets formed, and can

  • be evidenced by the chlorination reactions you

  • see of all your proteins.

  • So you can isolate chlorinated aromatics out of the phagosome.

  • So if we go through here--

  • let me just give you this one first.

  • So I've written this out for you in some detail.

  • Again, it's two electrons, one electron,

  • HOCl is two electrons.

  • And that's thought to be the predominant species,

  • but let me just tell you that--

  • so this is the one we're talking about in the handout.

  • This is the major reaction, but you can

  • do a lot of other reactions.

  • And so what you need to look at to see if these are important--

  • just like with superoxide, you need to look at the kinetics

  • of the reaction under the conditions where these

  • molecules find themselves--

  • to figure out what's really going on,

  • and how much these other pathways contribute.

  • [INAUDIBLE] actually just-- there's

  • a paper online in the annual reviews of biochemistry, where

  • she talks about the neutrophils in a lot of detail,

  • and the complexity of all this radical chemistry.

  • So what I want you guys to take home from this

  • is that we're working pretty hard with the NADPH oxidases,

  • to engulf a bacteria.

  • We're using reactive oxygen species, superoxide

  • and hypochlorus acid to try to do

  • in the bacteria inside the phagosome.

  • So that's all I want to say about this section

  • of reactive oxygen species, and now what I want to do

  • is talk about something we've already talked about,

  • because we've gone over this--

  • because we've gone over this in recitation.

  • We spent a couple of recitations on the Carrol paper.

  • And so I told you--

  • when I was introducing this, I gave you an outline

  • of where we're going.

  • We're going to reactive out of control versus controlled

  • hydrogen peroxide superoxide production and signaling.

  • So again, it's this thing all about-- it's

  • all about homeostasis.

  • Just need to get my act together here.

  • So where are we going with this?

  • This is the outline of where we're going to go,

  • and so I'm not going to write the outline, because it

  • will take me too long.

  • And I really want to get-- you can read

  • the outline on my PowerPoint.

  • But what I want to do very briefly

  • is give you an overview of how these reactive oxygen

  • species are thought, in general, to play a role in signaling.

  • A lot of people working on this--

  • there are many, many proteins involved.

  • We're only looking at one of these proteins,

  • the epidermal growth factor receptor, which we talked about

  • in recitation.

  • I also want to sort of give you an overview of the importance

  • of cysteines in general in the proteome,

  • and the role they play in this signaling process.

  • We'll see.

  • We are looking at one small modification, sulfenylation,

  • but we'll see that there are many other modifications.

  • And so I think one of the things for the future

  • is figuring out, like the Carrol paper did,

  • how biologically important are all these modifications

  • that we can now identify because of the amazing power of Mass

  • Spec and the creativity of chemists

  • to figure out how to generate reagents.

  • And so then I'll specifically introduce you

  • very quickly to NOX and growth factors in NOX2--

  • the big family of NOX2.

  • And then I'm going to talk about the general principles

  • of signaling, what's required.

  • And this is true of all signaling, not just with NOX,

  • but I'll use NOX as an example.

  • And then I will probably spend no time on this at all.

  • The last part is how do we know all of this?

  • We spent two recitations on this,

  • so I'll tell you the key things I want you to remember.

  • But you've now read papers.

  • You've thought about this.

  • And hopefully you can go back and think about it again,

  • and it will all sort of now make more sense to you.

  • OK, so where are we going?

  • And so what I want you to see is sort of the big picture--

  • so again, the overview.

  • And the overview now is not of the bad radicals

  • that we're talking about, but they are still

  • the bad radicals-- but controlling them in a way.

  • So in the radical systems we're going

  • to be looking at-- we're not going

  • to be looking at all of them.

  • But the signaling agents that we're going to be looking at--

  • so this is an overview of signaling.

  • The signaling agents we're going to be looking at

  • are superoxide, hydrogen peroxide, and NO.

  • And we've already talked about the fact

  • that we're not discussing NO, but in our department

  • in biomedical engineering, Tannibaum's lab

  • has been a major player in figuring out

  • how to look at the modifications of cysteines by NO.

  • It's not by NO.

  • It's by a metabolite of NO that then reacts with the cysteines.

  • So this is a very-- and he does that by Mass Spec,

  • so this is a very active area of research.

  • So now we're looking at signaling, not bad stuff.

  • And one of the things that-- where have we seen this before?

  • We've seen, although I don't think we realized it--

  • we were looking at iron homeostasis.

  • This is what happens when you get up at 4:00 in the morning.

  • OK, homeostasis.

  • Homeostasis.

  • And we have two proteins, the iron responsive binding protein

  • one and two.

  • And what do we know about iron responsive binding protein one?

  • It has an iron sulfur cluster.

  • And remember it has to go from the apostate

  • to the iron cluster state, so we have IRP 1,

  • and we go from the apo to the 4 iron 4 sulfur cluster.

  • And it's believed, but it has not been very well studied,

  • that this can be a sensor of oxidative stress,

  • and so both NO and reactive oxygen

  • species, such as hydrogen peroxide,

  • can cause the metal center to be destroyed.

  • And somehow you get to the apo state,

  • and that's an active area of research.

  • And then we know what the signals are.

  • You have translational control by iron responsive elements

  • at the five prime or the three prime end.

  • The same thing happens with IRP 2.

  • So I'm just trying to tie things together,

  • but does anybody remember what the sensor was with IRP 2?

  • Anybody remember what it did?

  • AUDIENCE: Ubiquitin ligase?

  • JOANNE STUBBE: The what?

  • AUDIENCE: Is it ubiquitin ligase?

  • JOANNE STUBBE: Yeah, so we had a little ubiquitin ligase

  • remain with the sensor that binds in ways we still

  • don't understand, so again this is

  • something that's very much an active area of research.

  • You have iron in oxygen--

  • sorry, LBX L5, leucine-5, domain of the ubiquitin ligase.

  • I'm not going to draw all of that out.

  • So again, these are all tied-- with what

  • happens with iron and oxygen, it's

  • all tied to these reactive oxygen species.

  • So what we've already talked about-- so

  • this is the major focus, our growth factors.

  • And I'll show you using PowerPoints,

  • but this kind of signal is signaling is also

  • involved in cell proliferation and cell differentiation.

  • So it's widely used in the example that we chose to use,

  • because it was one of the ones that's

  • been most carefully and recently characterized as EGF receptor.

  • EGF receptor is also of great interest,

  • because it's a target.

  • It's the target for successful drugs used clinically

  • in the treatment of cancer.

  • So we then have another.

  • So there are two other important signaling pathways that

  • are proposed to be involved.

  • One is called the antioxidant pathway,

  • and there is a transcription factor.

  • Some of you might have heard of it.

  • Has anybody heard of NRF2?

  • No.

  • So if you're more biological or--

  • have you heard of the antioxidant?

  • You're biological.

  • Have you heard of NRF2?

  • AUDIENCE: No.

  • JOANNE STUBBE: No.

  • OK.

  • So anyhow, we have an antioxidant pathway,

  • and NRF2 is a transcription factor.

  • And it turns out--

  • I'm not going to go through the details of this,

  • but for those of you who want to read about the details of this,

  • this is a cell signaling review article published, where

  • they go into all of the proposed mechanisms of how

  • these reactive oxygen species connect to signaling.

  • We're going to focus on epidermal growth factor

  • receptor, but I think you need to know

  • the picture is much bigger.

  • It turns out that NRF2 is in a complex with an E3 ubiquitin

  • ligase, and part of that ligase--

  • it's a multi enzyme complex--

  • is keap.

  • Keap has a huge number of cysteines on it.

  • These cysteines get oxidized by some kind of reactive oxygen

  • species.

  • In that one, you want to turn on your antioxidant defense.

  • And so what happens when Keap cysteines get oxidized.

  • It dissociates from NRF2, and NRF2 can go into the nucleus,

  • and it turns on a whole bunch of genes.

  • So I mean you're just getting the idea.

  • I'm not going to go through any details,

  • but it plays a central role.

  • And this system, if you google it,

  • you'll find there are hundreds of papers on this system.

  • This is a very interesting system.

  • I keep waiting for them to get to some stage

  • where I can really talk about the biochemistry,

  • but we aren't at that stage yet, in my opinion.

  • And then the other thing is DNA damage and repair.

  • And if you have DNA damage, or you're

  • starting to get oxidative stress,

  • and these things are out of control--

  • hydroxide radical is reacting with your nucleic acids--

  • you need to do something.

  • So you turn on a signaling pathway,

  • and this is controlled by a kinase.

  • I'm not going to go into this in detail, but some of you

  • might have heard of this.

  • This is called the ATM pathway, and what you see-- actually,

  • you'll see, I think, in the next five years if you remain

  • biochemist--

  • all these acronyms for all these pathways,

  • you're going to get it, because now we're seeing them

  • over, and over, and over again.

  • And at first, it was hard to see how this all fits together,

  • but we're getting there.

  • It's all fitting together, I think, in an interesting way.

  • So all I want you to get out of this--

  • we're going to be talking about growth matters,

  • but this is also a huge area, just like we just

  • saw with oxidative stress trying to kill our bacteria.

  • OK, so the next slide is one I took out of this article.

  • I'm not going to go through this in detail,

  • but we've already been through the iron

  • responsive binding protein.

  • So this is a summary of that, and we spent a lot

  • of time talking about this.

  • This is what we're going to talk about now--

  • the role of sulfenylation, in controlling kinase activity,

  • and phosphatase activity.

  • That's what we spent the last two recitation

  • sections talking about.

  • This is a generic approach to that,

  • and I'm going to show you there are many, many growth

  • factors that are thought to go through the same pathway.

  • And so I just want you to remember that.

  • So this is a big area, and so now the next thing

  • is-- so there's another sort of overview picture

  • I want you to get.

  • So there's a second overview picture

  • that I think is also important, and that cysteines really

  • are playing a major role in all of these modifications.

  • They are the easiest to oxidize, and so I

  • think cysteine modifications are important.

  • And there are many, many modifications.

  • The question is, do they happen inside the cell?

  • Do they happen inside the cell in a way

  • that we can connect them to some interesting biology?

  • And then what triggers off?

  • Ultimately, what triggers off these modifications?

  • So we've been talking about the kinases,

  • and we've been talking about sulfenylation.

  • That's what we spent two recitations on,

  • so that's one important thing.

  • But somehow, we're going to see that one

  • of the important things that I've

  • tried to stress in recitations was these reactions need

  • to be reversible, so ultimately sulfenylation-- some way,

  • come to this later.

  • But it's going to be able to be converted back

  • into the reduced state.

  • We've seen that you can form sulfonic acids.

  • This is also-- if you look at the Carrol paper carefully--

  • we didn't talk about this very much--

  • it's also reversible.

  • There are sets of enzymes.

  • Hydrogen peroxide can do the oxidation--

  • the back reaction that people have discovered an enzyme.

  • They can do the back reaction.

  • And then there's an irreversible step.

  • So people don't know, but because it's irreversible

  • this is likely not physiologically important.

  • So in addition to these states, if you

  • start reading the literature, or you read any literature now,

  • we have glutathione that we've talked about.

  • Glutathione is this tripeptide with glutamylcysteine glysine.

  • It is able to convert the sulfenic acid

  • into a glutathionlyated protein.

  • We're seeing these all over the place.

  • Is this the signaling pathway?

  • How is it controlled?

  • What's going on with these?

  • I think we don't know the answer to that.

  • So you can actually have glutathione react to give SSG.

  • You can also have other kinds of proteins that I think--

  • so here they have RSH.

  • This could be a thioredoxin protein,

  • which if we get to deoxy nucleotide formation,

  • there are hundreds of thioredoxins

  • inside the cell that do the same kind of thing.

  • And so one can also go from here,

  • so you can have a little protein called thioredoxin,

  • and it has two cysteines.

  • And it can convert this back into the SH,

  • and it itself can become oxidized.

  • And there's a way of cycling the thioredoxin.

  • So you're getting the idea, OK.

  • Over here in this model, we're not

  • going to talk about this, because I decided not to talk

  • about reactive-- not on nitrogen species,

  • but nitrous oxide can get converted into peroxynitrite.

  • Peroxynitrite is able to actually catalyze

  • formation of molecules like this, which is thought

  • to be involved in signaling.

  • They're also controlled reversibly by thioredoxins,

  • and again this is what the Tenenbaum Lab studies.

  • And these things can also cyclize

  • to form these kinds of structures.

  • So these are called sulfenamides.

  • People have found them.

  • They have X-ray structures of them.

  • Are they important in signaling?

  • I don't know, but you can see that you have many, many kinds

  • of modifications.

  • That's the takehome lesson from this,

  • and then the big question is how important

  • are these in terms of controlling homeostasis?

  • So what I want to do now is briefly look at the players.

  • I think I'm going to raise this.

  • But briefly look at the players we've already

  • started to look at, and make a few points,

  • and make the general points about the signaling process,

  • using epidermal growth factor receptor as an example.

  • And so I'm hitting you over the head with this

  • again, because we have already looked

  • at this a couple of times.

  • So we have an overview of EGFR and NOX.

  • So we just looked at NOX.

  • This is also NOX2.

  • It's the same protein.

  • They're found in different places.

  • And so remember with NOX2 we had all these factors

  • that I told you, if we're involved in the phagosome,

  • you had a GTPase, you had phagosome oxidase.

  • Now you have, in some cases, similar factors--

  • in other cases, additional factors--

  • that play a role in these multi enzyme complexes

  • that allow it to do something else, OK?

  • So nature reuses, over and over again, these different factors.

  • So this is the cartoon picture you guys have seen before.

  • We use this in recitation.

  • This is where I started to have you think about recitation 11,

  • when we started this, to try to introduce you to the system

  • again.

  • And so I just want to make a couple of points about this,

  • but here's our epidermal growth factor receptor, which you all

  • know now is a tyrosine kinase.

  • Here is the NOX protein, and here you can see we have Rac1.

  • If you go back, and you look at your notes from last time Rac1

  • is a GTPase.

  • You can control its activity with little proteins that

  • can bind to it and inhibit it.

  • And the funny thing about this, and people

  • were asking me questions about this,

  • is that the chemistry, the tyrosine kinase,

  • is in the inside of the cell.

  • NOX1, the NADPH-- and going to NADP is in the inside

  • of the cell just like we just talked about--

  • but where is-- because of the predisposition

  • of the flavin and the two hemes, where is superoxide produced?

  • On the outside of the cell.

  • That's rather bizarre.

  • This is still rather bizarre to me.

  • This is the model people have in the literature,

  • but you're reducing equivalents from NADPH

  • to convert oxygen to superoxide, which rapidly disproportionates

  • to form hydrogen peroxide.

  • And so then the question is we're

  • saying hydrogen peroxide is the key signaler that's

  • doing sulfenylation.

  • How does it get into the cell?

  • So the model then is it gets into the cell

  • through an aquaporin.

  • And is this aquaporin just moving around in the membrane,

  • or is this some organization within the membrane?

  • So this is going to be useful.

  • We've already talked about the fact

  • that hydrogen peroxide is not very reactive.

  • So one way you can get something to be more reactive

  • is by increasing its concentration.

  • So nature does this all the time.

  • So if you can somehow stick things together and generate

  • something, and it's generated right adjacent to where you're

  • going to react, it has a greater probability of reacting here

  • than over here.

  • And where have you seen that before?

  • Any of you thought about that?

  • Graduate students should know this.

  • AUDIENCE: DNA templated synthesis?

  • JOANNE STUBBE: DNA what?

  • AUDIENCE: DNA templated synthesis?

  • JOANNE STUBBE: No.

  • So, yeah.

  • No.

  • So you do, but I mean in terms of all of these reactive oxygen

  • species.

  • The Ting Lab, that's what she does.

  • She generates these things in the middle of the cell,

  • and it's all dependent-- how long can this go?

  • Remember we talked about this diffusion question.

  • How far does it go before it actually reacts?

  • So the idea, and the question you

  • need to ask yourself is, if you generate this,

  • are these organized?

  • Do you remember from the recitation?

  • Are these guys organized?

  • What did we learn the last time in recitation?

  • So we talked about-- we had this cartoon,

  • and we talked about this.

  • You looked at the data.

  • What did the data tell you?

  • Are these guys organized in some way,

  • so that this hydrogen peroxide can actually

  • do sulfenylation reactions?

  • So what was the evidence for that?

  • Does anybody remember?

  • I mean, so if you don't remember this, you need to go back,

  • and you need to read the paper again, OK?

  • And I have all of this stuff on a PowerPoint,

  • but I'm not going to go through it again.

  • Yeah?

  • AUDIENCE: There was colocalization

  • between, like, the NOX.

  • JOANNE STUBBE: Right.

  • So there was colocalization between the NOX2

  • in the growth factor, epidermal growth factor.

  • And what else was there colocalization from?

  • It's not shown here, but there was also colocalization

  • of a phosphatase-- which that's not shown in here,

  • but it's going to be shown in the next slide--

  • plays a key role in controlling the phosphorylation state.

  • OK, so this idea of--

  • I'm going to write this down because I think this

  • is a central idea in biology--

  • is how you localize things to make them more reactive.

  • Whether this makes it reactive enough--

  • it does make it reactive enough, because we can clearly

  • sulfenylate, but are we missing something on top of it,

  • to make it reactive enough to be able to do what we need to do?

  • So what we see with this system is EGF, the Growth Factor,

  • causes EGF dimerization.

  • That's what I've shown you in the cartoon over there.

  • I'm not going to draw out the cartoon,

  • because you've seen this cartoon a bunch of times.

  • And what does that do?

  • The tyrosine kinase activates itself by phosphorylation,

  • and we're going to come back to this.

  • So one way again, everybody has seen phosphorylations.

  • Whether they activate or inactivate, you need to study.

  • So here's the tyrosine kinase domain.

  • When they come together, it has activity

  • that it can phosphorylate itself,

  • so you get into this form which then

  • triggers signaling cascades.

  • So the other thing we need to think about in this paper

  • is-- so here we are going from the tyrosine

  • to the phosphorylated tyrosine.

  • You should write down that this is active.

  • How do you activate a phosphorylated tyrosine

  • if this is active?

  • You use a phosphatase.

  • So this, also, we saw in this paper.

  • And in this paper, this Carrol paper, she identified,

  • or she claims to have identified--

  • you can make your own judgment on that now--

  • the phosphatase, in the cell type that she looked at,

  • that played a key role in the tyrosine kinase activity.

  • So you're converting it from an active form

  • to an inactive form, which is what

  • you see by phosphorylation, dephosphorylation all the time.

  • I'm going to come back to this in a minute.

  • So here's a protein tyrosine phosphatase.

  • So we have a protein tyrosine phosphatase.

  • And so while I didn't write that out, these ends,

  • there are lots of different kinds of phosphatases.

  • But they have a thiolate in their active site,

  • and these things is attached to a tyrosine on a protein.

  • So here's our tyrosine kinase.

  • So what happens again is you use covalent catalysis

  • in two steps.

  • So you phosphorylate, and then you hydrolyze.

  • So you phosphorylate, and then you hydrolyze.

  • So you end up then with your tyrosine and the kinase,

  • and you end up back with ES minus.

  • So again, there are many different kinds

  • of phosphatases, but all the ones involved apparently

  • in these signaling processes-- if you go back and look

  • at the Carrol paper--

  • all have cysteines in their active site.

  • You've seen this, covalent catalysis with cysteine,

  • over, and over, and over again now at this stage.

  • So this is going to be a key control.

  • This is the active state, so this form is the active state.

  • And over here-- sorry.

  • So if you take this now, and you treat

  • this with hydrogen peroxide, this becomes sulfenylated,

  • and this becomes the inactive state.

  • So sulfenylation, just like with the tyrosine kinase

  • that we talked about in recitation,

  • can become activated.

  • The sulfenylation in this case becomes inactivated,

  • so that's what it's all about in these post

  • translational modifications.

  • And the question is--

  • I'm sorry, I'm over again.

  • But the question is are these models correct?

  • So what we'll do next time is spend a little bit

  • of time talking about the six general principles of post

  • translational modification, in general,

  • and what the expectations are using what you've already--

  • which we've already seen in recitations 11 and 12.

  • And then we're going to move on to the last module

  • on nucleotide metabolism.

The following content is provided under a Creative

Subtitles and vocabulary

Click the word to look it up Click the word to find further inforamtion about it